Anaemia in HIV-infected pregnant women receiving triple antiretroviral combination therapy for prevention of mother-to-child transmission: a secondary analysis of the Kisumu breastfeeding study (KiBS)

Tropical Medicine & International Health : TM & IH
Collins OdhiamboTimothy K Thomas

Abstract

The prevalence of anaemia during pregnancy is estimated to be 35-75% in sub-Saharan Africa and is associated with an increased risk of maternal mortality. We evaluated the frequency and factors associated with anaemia in HIV-infected women undergoing antiretroviral (ARV) therapy for prevention of mother-to-child transmission (PMTCT) enrolled in The Kisumu Breastfeeding Study 2003-2009. Maternal haematological parameters were monitored from 32 to 34 weeks of gestation to 2 years post-delivery among 522 enrolled women. Clinical and laboratory assessments for causes of anaemia were performed, and appropriate management was initiated. Anaemia was graded using the National Institutes of Health Division of AIDS 1994 Adult Toxicity Tables. Data were analysed using SAS software, v 9.2. The Wilcoxon two-sample rank test was used to compare groups. A logistic regression model was fitted to describe the trend in anaemia over time. At enrolment, the prevalence of any grade anaemia (Hb < 9.4 g/dl) was 61.8%, but fell during ARV therapy, reaching a nadir (7.4%) by 6 months post-partum. A total of 41 women (8%) developed severe anaemia (Hb < 7 g/dl) during follow-up; 2 (4.9%) were hospitalised for blood transfusion, whereas 3 (7.3%) were tran...Continue Reading

References

Jul 1, 1985·British Journal of Obstetrics and Gynaecology·M H HallR Carr-Hill
Dec 1, 1993·British Journal of Obstetrics and Gynaecology·R Pittrof
Apr 1, 1993·British Journal of Obstetrics and Gynaecology·V D Tsu
Jan 1, 1997·Archives of Gynecology and Obstetrics·D O Selo-Ojeme, F E Okonofua
Jun 3, 1998·British Journal of Obstetrics and Gynaecology·N van den Broek
Feb 13, 2001·The Journal of Nutrition·B J BrabinD Pelletier
Oct 6, 2001·AIDS Patient Care and STDs·R D SembaUNKNOWN HER (Human Immunodeficiency Virus Epidemiology Research) Study Group
Jan 31, 2002·American Journal of Public Health·Nancy L SloanBeverly Winikoff
Oct 9, 2003·Mayo Clinic Proceedings·Ayalew Tefferi
Nov 25, 2003·Hematology·Paul A VolberdingAlexandra M Levine
Jan 9, 2004·British Medical Bulletin·James McIntyre
Jan 9, 2004·British Medical Bulletin·Nynke van den Broek
Mar 11, 2005·The New England Journal of Medicine·Guenter Weiss, Lawrence T Goodnough
May 4, 2005·AIDS·Sarah TimmermansUNKNOWN Dutch HMF Study Group
May 11, 2006·Journal of Clinical Nursing·Candice BodkinGayle Langley
Dec 14, 2007·Tropical Medicine & International Health : TM & IH·Peter OumaLaurence Slutsker
Sep 30, 2008·PLoS Neglected Tropical Diseases·Simon BrookerDonald A P Bundy
Mar 31, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·N KumarasamyKenneth H Mayer
Jun 23, 2009·The Open AIDS Journal·Darin AreechokchaiWirach Maek-A-Nantawat
Jan 13, 2010·The American Journal of Tropical Medicine and Hygiene·Lokesh C MishraVirendra K Bhasin
May 27, 2010·Tropical Medicine & International Health : TM & IH·Jennifer L Smith, Simon Brooker

❮ Previous
Next ❯

Citations

Jul 13, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·K Tunkyi, J Moodley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.